Literature DB >> 16247070

Analysis of LRRK2 functional domains in nondominant Parkinson disease.

L Skipper1, H Shen, E Chua, C Bonnard, P Kolatkar, L C S Tan, R D Jamora, K Puvan, K Y Puong, Y Zhao, R Pavanni, M C Wong, Y Yuen, M Farrer, J J Liu, E K Tan.   

Abstract

A comprehensive sequence analysis of 29 exons that code for the functional domains of LRRK2 in 160 nondominant Parkinson disease (PD) patients was performed. Novel variant screening in a further 470 sporadic PD patients and 630 controls revealed two novel variants (R1067Q and IVS33 + 6 T>A), which are likely to be pathogenic in five patients. One patient presented initially with a typical essential tremor phenotype, expanding the phenotypic spectrum of LRRK2 mutations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16247070     DOI: 10.1212/01.wnl.0000180517.70572.37

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  14 in total

1.  The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence.

Authors:  E K Tan; Y Zhao; L Skipper; M G Tan; A Di Fonzo; L Sun; S Fook-Chong; S Tang; E Chua; Y Yuen; L Tan; R Pavanni; M C Wong; P Kolatkar; C S Lu; V Bonifati; J J Liu
Journal:  Hum Genet       Date:  2006-09-30       Impact factor: 4.132

2.  Lingo2 variants associated with essential tremor and Parkinson's disease.

Authors:  Yi-Wen Wu; K M Prakash; Tian-Yi Rong; Hui-Hua Li; Qin Xiao; Louis C Tan; Wing-Lok Au; Jian-qing Ding; Sheng-di Chen; Eng-King Tan
Journal:  Hum Genet       Date:  2011-02-02       Impact factor: 4.132

Review 3.  PARK8 LRRK2 parkinsonism.

Authors:  Kristoffer Haugarvoll; Zbigniew K Wszolek
Journal:  Curr Neurol Neurosci Rep       Date:  2006-07       Impact factor: 5.081

4.  Genetic variants of α-synuclein are not associated with essential tremor.

Authors:  Owen A Ross; Karen N Conneely; Tao Wang; Carles Vilarino-Guell; Alexandra I Soto-Ortolaza; Alex Rajput; Zbigniew K Wszolek; Ryan J Uitti; Elan D Louis; Lorraine N Clark; Matthew J Farrer; Claudia M Testa
Journal:  Mov Disord       Date:  2011-10-24       Impact factor: 10.338

5.  Prevalence of the LRRK2 G2019S mutation in a UK community based idiopathic Parkinson's disease cohort.

Authors:  C H Williams-Gray; A Goris; T Foltynie; J Brown; M Maranian; A Walton; D A S Compston; S J Sawcer; R A Barker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-05       Impact factor: 10.154

6.  Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations.

Authors:  A S Chen-Plotkin; W Yuan; C Anderson; E McCarty Wood; H I Hurtig; C M Clark; B L Miller; V M-Y Lee; J Q Trojanowski; M Grossman; V M Van Deerlin
Journal:  Neurology       Date:  2007-10-03       Impact factor: 9.910

7.  The nonsynonymous Thr105Ile polymorphism of the histamine N-methyltransferase is associated to the risk of developing essential tremor.

Authors:  Maria C Ledesma; Elena García-Martín; Hortensia Alonso-Navarro; Carmen Martínez; Félix Javier Jiménez-Jiménez; Julián Benito-León; Inmaculada Puertas; Lluisa Rubio; Tomás López-Alburquerque; José A G Agúndez
Journal:  Neuromolecular Med       Date:  2008-06-10       Impact factor: 3.843

8.  LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease.

Authors:  Cyrus P Zabetian; Mitsutoshi Yamamoto; Alexis N Lopez; Hiroshi Ujike; Ignacio F Mata; Yuishin Izumi; Ryuji Kaji; Hirofumi Maruyama; Hiroyuki Morino; Masaya Oda; Carolyn M Hutter; Karen L Edwards; Gerard D Schellenberg; Debby W Tsuang; Dora Yearout; Eric B Larson; Hideshi Kawakami
Journal:  Mov Disord       Date:  2009-05-15       Impact factor: 10.338

9.  Parkinson's disease and low frequency alleles found together throughout LRRK2.

Authors:  Coro Paisán-Ruiz; Nicole Washecka; Priti Nath; Andrew B Singleton; Elizabeth H Corder
Journal:  Ann Hum Genet       Date:  2009-05-21       Impact factor: 1.670

Review 10.  Zeroing in on LRRK2-linked pathogenic mechanisms in Parkinson's disease.

Authors:  Saskia Biskup; Andrew B West
Journal:  Biochim Biophys Acta       Date:  2008-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.